5 results on '"Chen, Shinn-Chern"'
Search Results
2. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients.
- Author
-
Yeh, Ming-Lun, Huang, Chung-Feng, Huang, Ching-I, Dai, Chia-Yen, Lin, I-Hung, Liang, Po-Cheng, Hsieh, Meng-Hsuan, Lin, Zu-Yau, Chen, Shinn-Chern, Huang, Jee-Fu, Chen, Jyh-Jou, Yu, Ming-Lung, and Chuang, Wan-Long
- Subjects
CHRONIC hepatitis B ,RECEIVER operating characteristic curves - Abstract
Background: Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA
+ -M2BP) was a novel marker of liver fibrosis. We aimed to investigate WFA+ -M2BP level in assessing liver fibrosis in patients with chronic hepatitis B (CHB) infection. Methods: A total of 160 CHB patients, who received a liver biopsy, were consecutively recruited. Serum WFA+ -M2BP level was quantified at the time point of biopsy. The results were compared with histopathological manifestations and clinical characteristics of the patients. Results: The median WFA+ -M2BP level, aspartate aminotransferase-to-platelet ratio (APRI) and Fibrosis-4 (FIB-4) index were 1.20 COI, 1.19, and 1.63, respectively. Fifty-one (31.9%) patients had advanced fibrosis. There was a significant increase of WFA+ -M2BP levels in parallel to necroinflammation/fibrosis stages. The areas under the receiver operating characteristic curve (AUROC) of WFA+ -M2BP level for predicting fibrosis stages were 0.780 of F2, 0.785 of F3, and 0.769 of F4, respectively (all p <0.001). The multivariate analysis identified age (Odds ratio [OR] 1.05, 95% confidence interval [CI]: 1.010–1.092, p = 0.014), platelet (OR: 0.99, 95%CI: 0.980–0.998, p = 0.013), and WFA+ -M2BP level (OR: 1.97, 95% CI: 1.299–2.984, p = 0.001) as independent factors associated with advanced fibrosis. Combination of age, platelet and WFA+ -M2BP level achieved a better diagnostic performance for advanced fibrosis (AUROC: 0.732, accuracy: 81.3%) than APRI (AUROC: 0.577, accuracy: 63.8%) or FIB-4 index (AUROC: 0.691, accuracy: 75.6%). Conclusion: WFA+ -M2BP had a good performance indistinguishing liver fibrosis in CHB patients. The combination of age, platelet, and WFA+ -M2BPaddressed more accuracy in identifying patients with advanced fibrosis. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
3. 25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacy.
- Author
-
Huang, Jee‐Fu, Ko, Yu‐Min, Huang, Chung‐Feng, Yeh, Ming‐Lun, Dai, Chia‐Yen, Hsieh, Meng‐Hsuan, Huang, Ching‐I, Yang, Hua‐Ling, Wang, Shu‐Chi, Lin, Zu‐Yau, Chen, Shinn‐Chern, Yu, Ming‐Lung, and Chuang, Wan‐Long
- Subjects
HYDROXY acids ,HEPATITIS C virus ,INFLAMMATION ,LIVER diseases ,VIRUS diseases - Abstract
Aim 25-Hydroxy vitamin D (Vit D) plays a role in treatment outcomes in chronic hepatitis C virus (HCV) infection. We aimed to clarify whether HCV replication is inhibited by Vit D in HCV replicon cells. Clinical implication was assessed for rapid virological response (RVR) and sustained virological response (SVR) among those patients receiving antiviral therapy. Methods Cell survival and viral loads were observed in Con1 (genotype 1b) and J6/JFH (genotype 2a) cells treated with different doses of Vit D. Three groups of patients with different treatment responses were recruited to assess their Vit D levels: group A, RVR−/SVR−; group B, RVR+/SVR−; and group C, RVR+/SVR+. Results The viral load of Con1 cells decreased by 69%, 80%, and 86% following treatment with 1 μM, 5 μM, and 10 μM Vit D, respectively ( P < 0.0001). In J6/JFH cells, it decreased by 12%, 55%, and 80.5% following treatment with 1 μM, 5 μM, and 10 μM Vit D, respectively ( P < 0.0001). There was a significant increase of Vit D between chronic hepatitis C groups, ranging from 4.4 ± 5.6 ng/mL in group A ( n = 44), to 17.2 ± 11.6 ng/mL in group B ( n = 44), and 32.5 ± 37.5 ng/mL of group C ( n = 44) ( P < 0.001). Advanced fibrosis (odds ratio = 0.13, 95% confidence interval = 0.04-0.41, P < 0.001) and Vit D deficiency (<10 ng/mL) (odds ratio = 0.11, 95% confidence interval = 0.03-0.43, P = 0.001) were predictive of SVR in the multivariate regression analysis. Conclusion Vitamin D decreases HCV replication and also contributes to early treatment viral kinetics. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
- Author
-
Huang, Jee-Fu, Yeh, Ming-Lun, Huang, Chung-Feng, Huang, Ching-I, Tsai, Pei-Chien, Tai, Chi-Ming, Yang, Hua-Ling, Dai, Chia-Yen, Hsieh, Meng-Hsuan, Chen, Shinn-Chern, Yu, Ming-Lung, and Chuang, Wan-Long
- Subjects
FATTY liver ,FATTY degeneration ,LIVER diseases ,BIOPSY ,FIBROSIS - Abstract
Background & aims: Identification of disease severity remains a challenge in the management of non-alcoholic steatohepatitis (NASH). Cytokeratin-18 (CK18), is a recently developed non-invasive biomarker for NASH. We aimed to assess the performance of CK18 in disease severity prediction among Taiwanese NASH patients. Methods: A total of 76 biopsy-proven NASH patients (54 males, age = 41.0 ± 13.5 years) were consecutively recruited. The optimal cutoff values of CK18 for each stage of fibrosis were correlated with their histopathological manifestations. Results: There were 23 (30.3%) patients of Metavir fibrosis stage 0 (F0), 32 (42.1%) patients of F1, 14 (18.4%) patients of F2, and 7 (9.2%) patients of F3-4, respectively. The CK18 levels among those patients of F0, F1, F2, F3-4 were 86.7 ± 75.6 U/L, 122.4 ± 123.8 U/L, 160.7 ± 120.4 U/L, and 507.3 ± 343 U/L, respectively (trend for P<0.001). The adjusted optimal cutoff value for F2 prediction was 312.5 U/L, yielding the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the accuracy of 96.4%, 28.6%, 77.9%, 75%, and 77.6%, respectively (P = 0.009). For the prediction of advanced fibrosis (F3-4), the adjusted optimal cutoff value was 374.5 U/L, yielding the sensitivity, specificity, PPV, NPV, and the accuracy of 97.1%, 54.1%, 95.7%, 66.7%, and 77.6%, respectively (P = 0.003). Among those patients without hyperuricemia, the PPV, NPV, and accuracy of CK18 reached 100%, 95.8%, and 96%, respectively (P<0.001). Conclusions: CK18 combined with uric acid measurement is a promising non-invasive biomarker for prediction of disease severity in NASH patients. Trial registration: ClinicalTrials.gov [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA.
- Author
-
Lin, Ya-Yun, Huang, Jee-Fu, Liu, Shu-Fen, Yu, Ming-Lung, Tsai, Chiu-Hung, Yang, Jeng-Fu, Lin, I-Ling, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Chern, Chang, Wen-Yu, and Chuang, Wan-Long
- Subjects
HEPATITIS B virus ,VIRAL hepatitis ,BLOOD plasma ,LIVER diseases ,GENES - Abstract
Detection and quantification for hepatitis B virus (HBV) DNA has been an essential tool in the clinical setting. We aimed to assess clinical performance of the RealArt HBV TM PCR (RealArt) assay and the COBAS TaqMan HBV (COBAS) assay. Serum levels of HBV DNA in 146 treatment-naive chronic HBV (CHB) Taiwanese patients (118 males, 47 HBeAg + ; mean age, 34.7±13.0 y) were determined by both assays. The detection rate by the RealArt assay was 85.6% (125/146), which was not significantly different from the COBAS assay (89.7%, 131/146). The detection rate was also not significantly different between both assays irrespective of HBeAg seropositivity. The 2 assays were also comparable regarding quantification rate (92.8%, 116/125 vs 93.1%, 122/131). There was a positive correlation in the 109 specimens measurable by both assays (r=0.94, p<0.001). The mean HBV DNA level measured by the COBAS assay was significantly higher than the RealArt assay (5.24±1.83 vs 4.79±2.09 log IU/ml, p<0.001). This study demonstrated that both RealArt and COBAS assays were comparable regarding clinical performance in HBV DNA measurement. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.